INBRAIN Neuroelectronics

Thanks Nasdaq for celebrating our $50M Series B financing led by imec.xpand. 🔥🔥🔥 New investors EIC Fund, Fond ICO Next Tech, CDTI-Innvierte and AVANÇSA, and existing investors Asabys Partners, Aliath Bioventures and Vsquared Ventures also participated, bringing the total amount raised since inception to $68 million. The company’s technology utilizes the unique properties of #graphene, a Nobel Prize-winning material known for its strength, flexibility, and conductivity. Read our press release: https://lnkd.in/eBvGGr93 Watch CEO Carolina Aguilar on Bloomberg Television: https://lnkd.in/e9MJjaNh

Nature Electronics spoke with our CEO & Founder Carolina Aguilar about our work on #graphene-based brain computer interfaces and our recent first-in-human procedures. #BrainComputerInterface #BCI #neurotechnology Graphene Flagship The University of Manchester Salford Royal Hospital Sharing the link: https://lnkd.in/eCpMGNwn

pharmaphorum speaks with our CEO Carolina Aguilar about our work at INBRAIN Neuroelectronics. 🧠🧠 Inbrain Neuroelectronics is a European company that is also working with BCIs, but is taking a different approach by using graphene-based neural technologies and by focusing its work on existing medicinal approaches. The company recently announced that it had secured Series B funding that totalled $50 million, which Inbrain will use to develop its BCI technology and support on-going clinical trials. The potential for #graphene to revolutionise #nanotechnology, particularly in the medical sphere, has been discussed for years. In the case of Inbrain, the material, which is the thinnest material known to science and stronger than steel, is used in the implantable neural processor. Read the full article by Ben Hargreaves: 👇👇 https://lnkd.in/eeQihZwm #BCI #neurotechnology Graphene Flagship

Medical Design & Outsourcing editor Jim Hammerand speaks with our CEO Carolina Aguilar about graphene-based #BCI technology and its unique advantages. 🧠🧠 “In this field, there is a race to put as many contacts as you want or you think you need,” Aguilar said. “.. But I think it’s not about who can put more contacts on the surface of the brain. It’s more about what those contacts can do clinically in a relevant and meaningful way for the patient. We can not forget about that, because this is not a technology race.” Read the article: 👇👇 https://lnkd.in/evr7HGNk

Graphene is a "seriously weird material... it is neither a metal, nor an insulator, nor even a true semiconductor" but twenty years after it was first isolated some companies have persevered and are brining its possibilities to light 💡 In a Science article "COMING OF AGE: Twenty years after the ballyhooed discovery of graphene, the atom-thin carbon sheets are finding their footing" Graphene Flagship partners: Graphene Engineering Innovation Center (GEIC) at Graphene - The University of Manchester, INBRAIN Neuroelectronics, Graphenea, TUDelft iGEM and imec are highlighted as companies that have not only found their footing, but are successfully demonstrating the application of graphene within key industries that will affect everyday life. 📖 Read the full article: https://lnkd.in/dz_bKx7Q

Dan Gnansia from INBRAIN Neuroelectronics reveals how graphene and AI are transforming brain technology. 🌐 A neural implant made of graphene has been successfully and safely used clinically for the first time during a surgical procedure. The device, developed by INBRAIN Neuroelectronics co-founded by Kostas Kostarelos, Professor of Nanomedicine at The University of Manchester, was used during a brain tumour resection surgery. The technology was able to differentiate between healthy and cancerous brain tissue with micrometer-scale precision. 💰 Backed by $50M in Series B funding, INBRAIN is set to accelerate the development of its graphene-powered BCI therapeutics for neurological conditions. Discover more about their pioneering work here: https://lnkd.in/ea5nCcEn

🛠️💡 Crear las circunstancias Para Carolina Aguilar, la visión es clave para atraer los aliados adecuados, abrir camino y alcanzar los objetivos. Descubre otros aprendizajes en el capítulo sobre INBRAIN Neuroelectronics. ¡Escúchanos en Youtube, Spotify, Ivoox y Apple Podcasts! 🎥 Youtube - https://lnkd.in/dT4WnHcu 🎙 Spotify - https://lnkd.in/eaYcmKeh 🎙 Ivoox - https://lnkd.in/eRDsGnZg 🎙 Apple Podcasts - https://lnkd.in/dNwkvsjU 💻 www.bioemprendedores.es Con el apoyo de SIMBIONTE | Digital Growth for Biotech

🆕 🎥 Esta semana tenemos el placer de conversar con Carolina Aguilar, #CEO y #cofundadora de INBRAIN Neuroelectronics. Inbrain es una empresa pionera en #neurología de precisión en tiempo real que ha desarrollado la primera plataforma terapéutica de interfaz cerebro-ordenador (#BCI-Tx) basada en #grafeno. Su tecnología combina la descodificación neuronal avanzada y la modulación micrométrica para ofrecer tratamientos personalizados y adaptables a afecciones como el Parkinson, la epilepsia y la rehabilitación del ictus. Además, hace unas semanas anunciaron una ronda de 50M de dólares que les permitirá respaldar los ensayos clínicos en curso, permitirá ampliar el equipo y seguir desarrollando la plataforma de la empresa impulsada por #IA para el tratamiento de enfermedades neurológicas. No te pierdas este episodio para conocer la historia de Carolina, una auténtica fuera de serie que tras convertirse en la responsable de negocio global de Medtronic, decidió emprender con Inbrain. Este caso es toda una masterclass en #deeptech. www.bioemprendedores.es Escúchanos en: - Youtube: https://lnkd.in/di-d-Utr - Spotify: https://lnkd.in/druexyDm - Ivoox: https://lnkd.in/deSF8ffQ - Apple Podcasts: https://lnkd.in/dNwkvsjU Este episodio es posible gracias a nuestros patrocinadores: - Solutia - Capital Cell - SIMBIONTE | Digital Growth for Biotech - Perdigó Medical - Medex Partners